C4 Therapeutics Files Definitive Proxy Materials
Ticker: CCCC · Form: DEFA14A · Filed: Apr 29, 2026 · CIK: 0001662579
| Field | Detail |
|---|---|
| Company | C4 Therapeutics, Inc. (CCCC) |
| Form Type | DEFA14A |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-governance
TL;DR
C4 THERAPEUTICS FILED PROXY DOCS - CHECK FOR VOTING INFO
AI Summary
C4 Therapeutics, Inc. filed a DEFA14A on April 29, 2026, which contains additional definitive proxy soliciting materials. The filing includes graphic documents and a complete submission text file, detailing information relevant to shareholder decisions. The company's business address is 490 Arsenal Way, Suite 120, Watertown, MA 02472.
Why It Matters
This filing provides shareholders with crucial information for upcoming votes, impacting corporate governance and strategic decisions at C4 Therapeutics.
Risk Assessment
Risk Level: low — This filing is a standard proxy statement update and does not inherently indicate new risks for the company.
Key Players & Entities
- C4 Therapeutics, Inc. (company) — Filer of the DEFA14A
- 0001662579 (company) — CIK number for C4 Therapeutics, Inc.
- 2026-04-29 (date) — Filing date of the DEFA14A
- 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (address) — Business and Mailing Address for C4 Therapeutics, Inc.
FAQ
What type of filing is this DEFA14A for C4 Therapeutics, Inc.?
This DEFA14A filing is for Additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this DEFA14A filing accepted by the SEC?
The filing was accepted on 2026-04-29 at 07:02:40.
What is the CIK number for C4 Therapeutics, Inc.?
The CIK number for C4 Therapeutics, Inc. is 0001662579.
What is the business address of C4 Therapeutics, Inc.?
The business address of C4 Therapeutics, Inc. is 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472.
What SIC code is associated with C4 Therapeutics, Inc.?
The SIC code associated with C4 Therapeutics, Inc. is 2836 Biological Products, (No Diagnostic Substances).
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 29, 2026 regarding C4 Therapeutics, Inc. (CCCC).